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Abstract
Background: Khat (Catha Edulis Forsk) is a natural psychoactive substance that contains addictive substances
such as Cathine and Cathinone which have similar structure and action to amphetamine. This substance has
been suggested that it can decrease perceived exertion and thus improve performance. There is no study in
the literature regarding the effect of khat on exercise performance. Therefore, the aim of this study is to find
out whether khat leaves can decrease perceived exertion in humans.
Methods: This study is an experimental crossover study conducted at the Substance Abuse Research Centre in
Jazan University, Saudi Arabia. Twenty one healthy volunteers were randomly assigned into two experiment trials.
Each volunteer visited the lab three times. The first visit was a familiarization session about the nature of the study
and the equipment. On the second visit, 45 min before the experiment volunteers ingested either 33 ml of fruit
juice (placebo) or the juice mixed with 45 g of ground khat leaves. Then the participants were instructed to
perform a 10 Km cycling on an ergometer and recorded the following physiological variables repeatedly on every
5 min of cycling: heart rate, time to complete 10 km cycling, tympanic temperature, and perceived exertion rate.
On the third visit a crossover trial was conducted one week after the second visit; then the same cycling test was
performed and the same variables were recorded as the second visit. The experimental protocol was reviewed and
approved by Research Ethical Committee of the Medical Research Centre, Jazan University.
Results: According to study results, khat dramatically decreased time taken to complete a 10 km cycling time trail
(p < 0.05), and significantly increased heart rate (p < 0.05) and tympanic temperature (p < 0.01). However, khat did
not reduce participant's perceived exertion during the physical trial. The Bonferrini simultaneous confidence
intervals using multivariate Hotelling’s T2 was performed to test the significance of the mean vectors for the
placebo group and the Khat group and found that groups are statistically significant.
Conclusions: Khat showed a clear enhancing effect on physical performance. The most parsimonious explanation
for this effect is that, like the related amphetamines, cathine/cathinone act as stimulants to increase the capacity to
perform exercise. Thus, khat produces the same effects which lead to the banning of amphetamine. These findings
conform & endorse the recent prohibition of cathinone by the World Anti-Doping Agency (WADA, 2014).
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Background
The use of stimulants for endurance in exercise-based
sports is not a new phenomenon; it dates back to the
times of ancient Greek Olympic Games (776 BC). Stimu-
lants are used to enhance performance and to delay
fatigue [1]. Amphetamine, cocaine and caffeine are the
most commonly used stimulants in sport [2]. Khat (Catha
edulis Forsk) is a mild stimulant that shares a pharmaco-
logical and structural similarity to amphetamine [3]. Khat
is commonly believed to improve work capacity and in-
crease energy levels and alertness [4]. Khat is often con-
sumed by people employed in exhausting jobs, such as
construction workers and long distance drivers, and by
students preparing for examinations [4–7]. Its use is per-
ceived to improve concentration and counteract fatigue
[4–7]. It is reported that Khat gives the users feelings of
euphoria and stimulation [8, 9].
Khat chewing is a very popular and deeply-rooted socio-
cultural tradition in regions of East Africa and the Arabian
Peninsula. This is especially well developed in Yemen
where it is used as a recreational drug even at social events
like weddings and meetings called “khat sessions” [10]. Khat
is chewed like tobacco and kept for a while in the cheek; to
suck and swallow its juice, along with some amount of
water to counter the bitter taste of the plant [10]. During a
typical event, a participant will chew 100–200 g of khat
[11]. It is estimated that there are now five to ten million
regular khat users in the world, with khat users spending 6
to 20 US$ per day on its use [3]. The main active ingredi-
ents of khat leaves are cathinone, cathine and Norephe-
drine. Cathinone and cathine are similar to amphetamine
in structure, effects and pharmacological activity but with
lower potency [11–16]. Cathinone is more potent than
cathine, and they are listed as Schedule I and IV drugs,
respectively [11, 13, 17–19]. The use of cathine (nor-
pseudoephedrine) is prohibited if its concentration in the
urine exceeds 5 micrograms per millilitre [20]. On Septem-
ber 11 2014, the World Anti-Doping Agency (WADA) had
added cathinone on the List of Prohibited Substances [21].
Despite the clear stimulant actions of khat, and historical
use of stimulants in physically demanding sports, there has
been a lack of studies investigating the effects of khat on
physiological functions of the body, such as endurance. The
main objective of this study was to investigate the physio-
logical effect of khat and perceived exertion during strenu-
ous exercise. Our approach compared the effects of khat
and placebo on resting heart rate, tympanic temperature,
time taken to complete a standardized 10 km cycle track,
and rating of perceived exertion.
Methods
Study participants
The study was carried out among young healthy human
volunteers. They were mostly students at Jizan University
and members of a local football team. Some of the volun-
teers were not students. The volunteers were regular and
irregular Khat users and in a good health. This was con-
firmed by the following inclusion criteria: participants
should not have any heart problem, no chest pain when
doing activities, not currently taking any medication for a
health problem. In total, 21 volunteers were recruited.
Their average age was 23.4 years ± 2.2 years, and average
weight was 66.8 kg ± 5.6 kg. All participants completed all
trails. There were no drop outs or injuries.
Design and procedures
This study is an experimental crossover study conducted
at the Substance Abuse Research Centre in Jazan Uni-
versity, Saudi Arabia. Tests started in early December
2011 and finished about 3 months later. All participants
completed two trials one after consuming a placebo and
the other after consumption of Khat. The order in which
the tests were conducted was randomized. The partici-
pants were blinded to the nature of the test. The author
was not blinded because he had to make up the drinks.
Since, the results were recorded by machine we hope
the experimenter effects and biases are very minimal. A
statistical power test on pilot data suggested that the
number of subjects required to carry out this experiment
is 21 subjects. The sample size calculated was based on
standard deviation of 1.0, expected effect size of 0.643
(Cohen’s d, a measure of effect size), power level of 0.80
and alpha of 0.05 [22].
Each volunteer visited the lab three times (baseline/
familiarization and the two test days). On the first visit a
familiarization session was conducted to make volun-
teers become familiar with the nature of the study and
the equipment, then consent to proceed was sought and
a simple health questionnaire was completed. On the
second visit, 45 min before the experiment volunteers
ingested either 33 ml of fruit juice (placebo) or the juice
mixed with 45 g of ground khat leaves which had been
filtered to remove particles — on average 100 g of khat
leaves there are 114 mg cathinone, 83 mg cathine and
44 mg norephedrine [10]. The time interval period of
1 week was chosen to avoid fatigue effects and loss of
concentration. Previous studies indicate that this time
period allows adequate time for absorption of khat [23].
Also, the maximal concentration effect of cathinone is
expected 15–45 min after an oral ingestion [24].
After ingestion of the drink, participants were instructed
to perform a 10 Km cycling on a RacerMate CompuTrainer
cycle ergometer and recorded the following physiological
variables repeatedly on every 5 min of cycling: heart rate,
time to complete 10 km cycling, tympanic temperature,
and perceived exertion rate. On the third visit (the cross-
over session) the participants returned to the lab after 7 days
at the same time of last tests and each participant ingested
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the other drink given in the second session; then the cycling
test was performed and the same variables in the second
session were recorded. The 1 week time interval was
chosen to avoid fatigue effects and loss of concentration.
Previous studies show this allows adequate time for absorp-
tion of khat. (See Fig. 1).
Instruments and measurements
There were two CompuTrainer sets in the lab. During the
cycling trials some of the riders were tested in pairs to
allow for some sense of competition while others were
tested in isolation and the essence is that this study is not
two man race assessments. All 21 riders were tested in
both trials (khat and placebo). All pairs of experiments
were conducted in the similar conditions. The laboratory
was air conditioned and the temperature was maintained
at 21 °C. Some volunteers preferred to exercise with the
laboratory windows opened. The experiments were con-
ducted during the winter in Jizan when the outside
temperature could be about 30 °C.
10 Km cycle tests
The test used a RacerMate CompuTrainer cycle ergom-
eter to provide a simulation of a 10 km time trial
(http://www.racermateinc.com/computrainer/). The erg-
ometer is controlled by a laptop computer and the soft-
ware delivers specific load to replicate ascents, and
descents. The CompuTrainer_TimeTrail.3 dc course was
used for tests. The distance of this course is 10 km and it
contains mix of climbs and descents. The Computrainer
screen simulates the participants during the experiment,
where the screen shows the performance of the competi-
tors during the race time. The Computrainer screen is
shown in Fig. 2.
Heart rate
Heart Rate was measured continuously during cyc-
ling by Polar FT1 Heart Rate Monitor Watch, U.K
(http://www.fitnessmegastore.co.uk/heart-rate-monitors-
87.html). It is shown in Fig. 3 below. The heart rate was
recorded every 5 min during the trial.
Temperature
Each participant’s tympanic membrane temperature was
recorded using an Omron Digital Ear Thermometer,
(mp 510 MC-510-E2, Omron Healthcare, Kyoto, Japan
LTD). This was recorded after each heart rate measure-
ment. This procedure is shown above in Fig. 3.
Rate of Perceived Exertion (RPE)
The volunteers rating of perceived exertion was measured
every 5 min during the time trial with a Borg 20-point
scale [25]. The English version of the scale has been trans-
lated into Arabic by the staff in King Saud University. The
translation procedure involved forward and backward
translation from English to Arabic language. The ques-
tionnaire was assessed for face and content validity by a
group of local experts in the field. Prof Hazza’s group had
used this translation successfully for several years. This
procedure is shown in Fig. 3.
Statistical analysis
All data were collated in Microsoft Excel 2010 and the
following statistical software were used for data ana-
lysis: SPSS version 18 was used for paired-sample t-test
analysis and repeated measures analysis (ANOVA),
Minitab version 16 was used for graphical analysis and
finally SAS version 9.3 was used for multivariate ana-
lysis. The data were first tested to confirm the assump-
tions of repeated measures ANOVA such as normality,
Sphericity and equality of variances condition. Subse-
quently, graphical analysis and paired t-tests were used
to compare the mean differences of the group; this de-
termines whether there is significant mean difference in
heart rate, perceived exertion and temperature scores
among participants in the two trials (khat and placebo).
Repeated Measures Analysis of Variance (ANOVA)
was utilized to find the effect of group differences in
heart rate, perceived exertion and temperature. We
tested both the within-subject effects and between-
subject effects of the model factors. The experimental
design used was essentially a two-factor (time point and
treatment) experiment with repeated measures of 5 re-
sponses on both factors. In each model, the subject is
entered as a random factor while Time Point and Treat-
ment (placebo and khat) and the interaction between
Time Point and Treatment were entered as between-
subjects factors. The Levene statistic test was used to
assess the assumption of equality of variances in the
study variable of the two trial groups. The Bonferrini
simultaneous confidence intervals using multivariate
Hotelling’s T2 was performed to test the significance of
the mean vectors for the placebo group and the Khat
group.
Cycling 10 km (20-35 minutes) 
Time (min) (45 m rest)    0          5          10        15        20        25        30   
-      = measurements of RPE, HR, and Temp respectively every time points.  
-                 = First day.                     = Placebo day.                       = Khat day. 
-       = ingestion. 
-       = Start of cycling. 
Fig. 1 The experimental protocol of the study
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Ethical approval
This study was conducted in accordance with the eth-
ical guidelines of the Declaration of Helsinki; and it had
been approved by Research Ethics Committee (REC) of
the Medical Research Centre (MRC), Jazan University
(Reference number 110). After approval of the study
protocol by the Research Ethics Committee, informed
consent was obtained from all participants. Participants
were told they could withdraw from the experiment at
any time. No volunteers withdrew during the experi-
ment. Volunteers were not paid for participating. Any
minor financial costs such as travel expenses were re-
paid from the project budget. The risks associated to
this study were very minimal and provision was made
to cover any medical costs associated with the experi-
ments. Some side effects which may occur as a result of
taking the khat leaves are: increased heart rate, blood
pressure, headaches, restlessness and alertness. The
study participants were regular and irregular khat
chewers and the given khat dosage (45 g) is quite con-
servative therefore we do not expect any serious side
effects to occur.
Results
Time taken to complete 10 km cycle
The time taken to complete the time trial was reduced
after taking khat when compared to placebo for each
participant (Fig. 4). Only one person cycled the route
slower after consumption of khat. The other 20 volun-
teers were faster. The difference in times in the two
conditions appears to be smaller for the faster cyclists,
say those who took less than 1600 s, than it is for the
slower cyclists. The minimum time required for cyc-
ling 10 km is not much different (0.4 %) between
placebo and khat. The maximum times were more
Fig. 2 Shows the CompuTrainer_TimeTrail.3 dc course and the distance of this course
Fig. 3 This shows details of the experimental measurement of time trial, perceived exertion, heart rate and core temperature. The computrainer
device is shown in the left panel. Details of the rate of perceived exertion scale (Borg’s RPE 20-point Scale) and Polar Heart Rate Monitor are in
the middle panel. The right panel shows a volunteer whilst their temperature is measured
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different (4.7 %), 34 min 17 s after placebo and 28 min
30 s after consuming khat (See Fig. 4).
On average, after consuming khat the trial was com-
pleted 168.1 s faster than when using the placebo. The
mean time after placebo was 1554 ± 230 s. The mean
time after consuming khat was 1386.2 ± 156 s. When
these times were compared using a paired t-test the re-
sult was highly significant (t = 5.88, df = 20, p < 0.001).
The magnitude of the change was not uniform across
the group of volunteers. It is easy to see in Fig. 4 that
the improvement in the faster cyclists is relatively uni-
form. Those who complete the placebo trial in 1600 s or
less improve by about 10 % after consumption of khat.
The five slowest cyclists make much larger improve-
ments of about 15 to 25 %. This differential effect makes
the analysis more complicated because the assumptions
of the General Linear Model are not secured.
The software recorded the mean power output of each
volunteer over the time trial. 19 of the 21 volunteers in-
creased their power after consumption of khat. The mean
increase was 21 watts. The range was from increase of 61
watts to a decrease of 7 watts. A paired t-test showed that
the mean power after consumption of khat was signifi-
cantly higher (t = 7.12, df = 20, p < 0.001) (See Fig. 5).
Physiological measures and Khat consumption
Heart rate
In both placebo and khat groups, heart rate rises during
the first 5 min of exercise and then is stable during the
exercise (See Fig. 6). At all time-points, the mean heart
rate was increased in khat consumption group: khat
group heart rate increase was 12.1 BPM at t = 0 and 19.9
BPM at t = 20. Comparison of mean heart rate toward the
end of the trial shows this increase in heart rate is signifi-
cant (t = 8.077, df = 20, p < 0.001; 15.8 + 11.5 bpm higher).
Note that the time trial is completed earlier after con-
sumption of khat.
Temperature
Tympanic temperature appears higher after khat inges-
tion, but this is only significant later in the trial (See
Fig. 7). There was no significant difference between the
mean temperature of the placebo and khat groups early
in the trial: at time 0 [t = 1.550, df = 20, p > 0.05], at time 5
[t = 1.420, df = 20, p > 0.05], or at time 10 [t = 1.540, df =
20, p > 0.05], but later in the trial the increase in
temperature of the khat group become significant: at time
15 [t = 4.038, df = 20, p < 0.001] and at time 20 [t = 3.452,
df = 20, p < 0.001].
Perceived exertion
The mean RPE scores for both time trials are plotted in
Fig. 8. It is clear that the scores are very similar at the
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Fig. 4 This figure plots the time to complete the 10 km time trial
after consuming khat or placebo for all 21 volunteers. Only one
person took longer to complete the 10 km cycle when using khat
while most volunteers finished about 2–3 min faster when using
khat. To find out if there is a significant change in the time required
to complete the 10 km cycle between using the placebo and khat,
the differences in time taken were calculated
Power 
Time 
Fig. 5 This shows the difference in mean power (khat minus placebo)
against the time taken to complete the trial on placebo for each
participant. The zero line shows no difference between the two trials.
Points above the line indicate increases in power. Points below the line
show decreases
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Fig. 6 This show the mean heart rate and SEM after taking the
placebo (P) and khat (K). There is a clear increase on the means of
heart rate in both khat day and the placebo day during 5 min after
starting then steady. The heart rate after consumption khat is higher
at all-time points comparing with taking placebo. Red symbols show
data from the placebo day and the black symbols from the khat day.
The last point on red symbols appears no bar because there is only
one person took longer time to complete the trial course
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same time points in both trials up to 20 min. That
means, the mean perceived exertion at the five time tri-
als in both groups (khat and placebo) are not signifi-
cantly different from one another at time point 5 (t =
0.940, df = 20 p = 0.358); at time point 10 (t = 0.779, df
= 20 p = 0.445); at time point 15 (t = 0.574, df = 20 p =
0.572) and at time point 20 (t = 0.748, df = 20 p = 0.748).
Measures of physiology and perceived exertion
The Hotelling’s T2 value is 26.14 and F = 4.705 with de-
grees of freedom 5 and 36. The p-value for the test is
0.00208 and we conclude that the mean vectors for the
placebo group and the Khat group are statistically sig-
nificant. This multivariate test takes into account the
positive correlation between the two measurements for
each group – information that is unfortunately ignored
by the univariate tests (See Table 1 and Fig. 9).
Repeated measures analysis (ANOVA)
The Mauchly’s test indicated that the assumption of
sphericity in the model had been violated (HR χ2 71.806,
df = 9, p < 0.001; for Temp χ2 71.806, df = 9, p < 0.001 and
for RPE χ2 71.806, df = 9, p < 0.001) that means the covari-
ance matrix assumption was not met, therefore the F-
values were corrected using the Greenhouse-Geisser test.
The results of the Anova indicated a significant time effect
of the Within-Subjects of the following three variables
Heart Rate (F = 177.257, df1 = 4, df2 = 1.412, p < 0.01),
Temperature (F = 2.511, df1 = 4, df2 = 2.301, p < 0.05), and
RPE (F = 152.675, df1 = 4, df2 = 2.090, p < 0.01); that means
we reject the null hypothesis of equal means in these
variables. The within subject test indicated that there is a
significant time effect in the model, that means, the
experiment groups (placebo and khat) effects do change
over time and will get higher heart rate, higher
temperature and higher RPE over time. In addition, the
Within-subject test also indicated that there were no
significant interaction effects in any of the variables –
session and time (HR F = 0.523, df = 1.412, p > 0.05; for
RPE F = 0.442, df = 2.090, p > 0.05; Temp F = 3.157, df = 1,
p > 0.05). To conserve space, details of the results of the
Main effects plot & the interaction plot are available upon
request.
The results of Between-Subjects Effects indicated a
significant main effect of a session (placebo and khat) in
heart rate (F = 15.387, df = 1, p < 0.05), and tempreture
(F = 9.335, df = 1, p < 0.01), while no difference was
found between RPE scores in placebo and khat (F =
0.059, df = 1, p > 0.05). Finally, the equality of variances
condition was fulfilled as the p-values of Levene’s test
were greater than 0.05 across all the three variables in
the study. We can conclude that the differences between
condition Means are likely due to chance and not likely
due to khat consumption.
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Fig. 7 This shows the mean and SEM of temperature for all
volunteers after taking either the placebo (P) or khat (K). Red
symbols indicate the placebo day and black the khat day. The
temperature rises after khat consumption and falls later after 20 min.
While temperature rises for 10 min after consuming the placebo
then it becomes unstable
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Fig. 8 This shows the mean (and SEM) of rate of perceived exertion
of all volunteers after consuming khat and after taking the placebo.
Red symbols show data from the placebo day and the black
symbols show data from the khat day. There are increases in the
both means of perceived exertion during the khat and placebo trials
Table 1 Multivariate calculations for Measures of physiology
and perceived exertion
Time Placebo
Mean(sd)
(n = 21)
Khat
Mean(sd)
(n = 21)
95 % Confidence Interval
Bonferroni Simultaneous
0 103.2
(658.3)
115.3
(539.8)
−40.1–15.9 −32.5–8.3
5 157.2
(414.5)
173.9
(234.6)
−37.3–3.9 −31.7– −1.7
10 161.7
(305.3)
176.1
(151.3)
−31.7–2.9 −27.0– −1.8
15 158.9
(250.1)
175.0
(134.7)
−32.0– −0.2 −27.7– −4.5
20 162.8
218.0)
182.7
(154.7)
−35.5– −4.3 −31.3– −8.5
Sallam et al. Substance Abuse Treatment, Prevention, and Policy  (2016) 11:18 Page 6 of 9
Discussion
The primary aims of this study was to investigate the ef-
fects of khat consumption on physiological factors in a
period of self-paced, moderate intensity exercise lasting
20 to 30 min. Permission was obtained to test 21 normal
healthy young men. They all completed the experiment
without ill effects. After consuming khat the time taken
to complete a 10 km cycling time trial was reduced, the
mean work rate was increased, the mean heart rate and
tympanic temperature were higher; see Fig. 4, Fig. 5,
Fig. 6 and Fig. 7.
The main finding in the present study indicated that
the time to complete 10 km time trial was reduced from
a mean of 1554.3 ± 230.7 s to a mean of 1386.2 ± 156.8 s
after consumption of khat (t = 13.169, df = 20, p < 0.001).
Over the period of the time trial, the mean of heart
rate and tympanic temperature were significantly
higher ([t = 8.077, df = 20, p < 0.001] and [t = 3.452, df
= 20, p < 0.005] respectively) after khat consumption
when compared with the placebo. The specific reason
for assessing tympanic pressure is that khat is associ-
ated with increase in diastolic blood pressure and cyc-
ling for untrained personal usually increases blood
pressure [26]. The Bonferrini simultaneous confidence
intervals using multivariate Hotelling’s T2 test reveals
that the mean vectors for the placebo group and the
Khat group are statistically significant (See Fig. 9 &
Table 1).
The heart rate was higher and stable throughout the
experiment; see Fig. 6. The temperature rises in placebo
trial and then returns to normal, see Fig. 7. Khat trial
rises temperature for longer to higher peak value then
begins to come down, more heat due to produce high
work then slowly return to normal. Heat loss as sweat
mechanism maybe led to temperature homeostasis after
the increase as a response to the feedback afferent from
central and peripheral sensors [27, 28]. This result from
the present experiment is in accord with many of
studies [29–33] which reported in literature review that
consumption of khat induces to increase the body
temperature after chewing.
The perceived exertion of the volunteers was measured
with a Borg scale, after translation to Arabic by the staff in
the exercise physiology laboratory in King Saud University
in Saudi Arabia. They have considerable experience of
using this successfully with Arabic speakers. The effective-
ness of the use of Borg scale may differ between volun-
teers according to their individual evaluation of their
perceptions. This may be a small problem since the same
volunteers were tested twice and their differences were
measured.
The results clearly show that consumption of khat im-
proves cycling time trial performance. The results of this
study show that participants worked harder and improve
their performance after khat consumption. They had
higher heart rates and tympanic temperatures. In addition,
they probably have higher oxygen consumptions but no
equipment to measure oxygen consumption was available
at the time of doing these experiments at SARC. Con-
sumption of khat must have a significant action on the
mechanisms responsible for perceiving exercise intensity.
To our knowledge, no previous investigation had mea-
sured the rate of perceived exertion during a khat trial.
The present investigation not only the first to measure the
rate of perceived exertion (RPE) during prolonged exercise
following khat ingestion, but also the first dosage of khat
that have been shown to alter exercise performance.
The participants in this study were all novice cyclists.
However, they are all young fit men most of whom engage
in regular sporting activities such as playing football,
without displaying any particular training history. Using
cycling as an exercise modality was necessary there was
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Fig. 9 The plot of the Average heart rate of Plesbo and Khat using Bonferroni simultaneous confidence intervals
Sallam et al. Substance Abuse Treatment, Prevention, and Policy  (2016) 11:18 Page 7 of 9
no treadmill in the SARC centre at the time of experi-
ment. Cycling is not common in Jizan and all the vol-
unteers, except two, were novices. This was offset by
allowing time for familiarization with the cycles. The
Computrainer ergometer provided consistent tests and
allowed the workload to be estimated.
There is an interesting possibility that the effect of khat
in improving exercise performance is mediated through
the ‘central governor model’ proposed by Noakes rather
than through improved cardiovascular performance. The
central prediction of the central governor model is that
the central nervous system determines the work rate that
can be sustained for the anticipated duration of exercise,
as well as the moment of exercise terminates. Thus, the
brain does not recruit additional motor units during pro-
longed exercise because that would threaten the capacity
to maintain homeostasis which would in turn lead to the
termination of exercise, organ damage or failure. As a re-
sult, the brain paces the body during exercise to ensure
that the activity is completed without any loss of cellular
homeostasis [27, 28].
During exercise continuous feedback from many sys-
tems in the body will inform the central controller of
the state features such as fuel reserves and the rate of
heat accumulation state among other variables. This
continuous feedback is integrated to regulate the exer-
cise intensity [27, 28, 34, 35]. The most likely action of
Khat is to change the relationship between the inputs
and outputs so that higher exercise intensities are toler-
able. This is seen in the increased tympanic membrane
temperature of volunteers, the higher heart rates and
higher work rates yet the RPE values lower at the end
of the exercise period. These results clearly show that
consumption of khat improves cycling performance.
The heart rate and core temperature are higher but the
perceived exertion is lower.
Limitations and future research implications
The limitations of the current study include: 1) the
study did not compare the perceived exertion of the
athletic and non-athletic groups of the study volun-
teers; 2) some of the volunteers were regular khat
users while other irregular khat users therefore we do
not know how might this have affected results; and 3)
during the cycling trials some of the riders were tested
concurrently while others were tested in isolation and
the study did not control this factor. Hence, all the re-
search limitations highlighted above needs to be ex-
plored further, and could be a focal point for future
studies. Finally, we recommend future researchers to
investigate the ergogenic effects of khat extract and
using variables such as grip strength, reaction time,
and blood pressure etc.
Conclusion
This study is the first to investigate the effects of khat
on physiological functions of the body, during strenuous
exercise. These results clearly showed that khat con-
sumption leads to higher work rates and improves per-
formance in addition to reductions in the fatigue. It is
speculated that cathine/cathinone exert a central action
to increase the capacity to perform exercise. Thus, khat
produces the same effects which lead to the banning of
amphetamine. These findings conform & endorse the re-
cent prohibition of cathinone by the World Anti-Doping
Agency (WADA, 2014).
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